-
Something wrong with this record ?
The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma
P. Skalicky, O. Urban, J. Ehrmann, H. Svebisova, D. Klos, J. Tesarikova, C. Neoral, K. Knapkova, M. Lovecek
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
34467956
DOI
10.5507/bp.2021.043
Knihovny.cz E-resources
- MeSH
- Cholangiocarcinoma * surgery pathology MeSH
- Humans MeSH
- Bile Duct Neoplasms * surgery pathology MeSH
- Pancreaticoduodenectomy MeSH
- Prognosis MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Bile Ducts, Intrahepatic pathology MeSH
- Check Tag
- Humans MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: The aim of the study was to calculate the short-term and long-term outcomes of curative-intent surgery in distal cholangiocarcinoma (DCC) patients to identify potential prognostic factors. PATIENTS AND METHODS: A retrospective cohort study of 32 consecutive DCC patients treated with pancreaticoduodenectomy between 2009-2017. The clinicopathological and histopathological data were evaluated for prognostic factors using the univariable Cox regression analysis. The Overall Survival (OS) was estimated using the Kaplan-Meier analysis. RESULTS: The study comprised a total of 32 patients, with a mean age of 65.8 (± 9.0) years at the time of surgery. R0 resection was achieved in 25 (86.2%) patients, 19 (65.5%) patients received adjuvant oncological therapy. The OS rates at 1, 3 and 5 years were 62.5%, 37.5% and 21.9%, respectively. The 90-day mortality was 3/32 (9.4%) accounting for one-fourth of the first-year mortality rate. The median OS was 28.5 months. The only statistically significant prognostic factor was vascular resection, which was associated with worse OS in the univariable analysis (HR: 3.644; 95%-CI: 1.179-11.216, P=0.025). An age less than 65 years, ASA grade I/II, hospital stay of fewer than 15 days, R0 resection, lymph node ratio less than 0.2 and adjuvant oncological therapy tended to be associated with better OS but without statistically significant relevance. CONCLUSION: The main factor directly influencing the survival of DCC patients is surgical complications. Surgical mortality comprises a significant group of patients, who die in the first year following pancreaticoduodenectomy. Vascular resection is the most important negative prognostic factor for long-term survival.
Department of Oncology University Hospital Olomouc Czech Republic
Department of Surgery 1 Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic
Department of Surgery 1 University Hospital Olomouc Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22029538
- 003
- CZ-PrNML
- 005
- 20230118155254.0
- 007
- ta
- 008
- 230113s2022 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2021.043 $2 doi
- 035 __
- $a (PubMed)34467956
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Skalický, Pavel $u Department of Surgery I, University Hospital Olomouc, Czech Republic $7 xx0102179
- 245 14
- $a The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma / $c P. Skalicky, O. Urban, J. Ehrmann, H. Svebisova, D. Klos, J. Tesarikova, C. Neoral, K. Knapkova, M. Lovecek
- 520 9_
- $a BACKGROUND: The aim of the study was to calculate the short-term and long-term outcomes of curative-intent surgery in distal cholangiocarcinoma (DCC) patients to identify potential prognostic factors. PATIENTS AND METHODS: A retrospective cohort study of 32 consecutive DCC patients treated with pancreaticoduodenectomy between 2009-2017. The clinicopathological and histopathological data were evaluated for prognostic factors using the univariable Cox regression analysis. The Overall Survival (OS) was estimated using the Kaplan-Meier analysis. RESULTS: The study comprised a total of 32 patients, with a mean age of 65.8 (± 9.0) years at the time of surgery. R0 resection was achieved in 25 (86.2%) patients, 19 (65.5%) patients received adjuvant oncological therapy. The OS rates at 1, 3 and 5 years were 62.5%, 37.5% and 21.9%, respectively. The 90-day mortality was 3/32 (9.4%) accounting for one-fourth of the first-year mortality rate. The median OS was 28.5 months. The only statistically significant prognostic factor was vascular resection, which was associated with worse OS in the univariable analysis (HR: 3.644; 95%-CI: 1.179-11.216, P=0.025). An age less than 65 years, ASA grade I/II, hospital stay of fewer than 15 days, R0 resection, lymph node ratio less than 0.2 and adjuvant oncological therapy tended to be associated with better OS but without statistically significant relevance. CONCLUSION: The main factor directly influencing the survival of DCC patients is surgical complications. Surgical mortality comprises a significant group of patients, who die in the first year following pancreaticoduodenectomy. Vascular resection is the most important negative prognostic factor for long-term survival.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a pankreatoduodenektomie $7 D016577
- 650 12
- $a nádory žlučových cest $x chirurgie $x patologie $7 D001650
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a cholangiokarcinom $x chirurgie $x patologie $7 D018281
- 650 _2
- $a žlučové cesty intrahepatální $x patologie $7 D001653
- 650 _2
- $a prognóza $7 D011379
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Urban, Ondřej, $u Department of Internal Medicine II - Gastroenterology and Geriatrics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1965- $7 stk2008428564
- 700 1_
- $a Ehrmann, Jiří, $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1967- $7 jo2003163162
- 700 1_
- $a Švébišová, Hana, $u Department of Oncology, University Hospital Olomouc, Czech Republic $d 1967- $7 ntk2011648828
- 700 1_
- $a Klos, Dušan $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $7 xx0081738
- 700 1_
- $a Tesaříková, Jana $u Department of Surgery I, University Hospital Olomouc, Czech Republic $7 xx0228946
- 700 1_
- $a Neoral, Čestmír, $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1952- $7 xx0000421
- 700 1_
- $a Knápková, Kateřina $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $7 xx0258820
- 700 1_
- $a Loveček, Martin, $u Department of Surgery I, University Hospital Olomouc, Czech Republic $d 1971- $7 xx0078672
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 166, č. 4 (2022), s. 386-392
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34467956 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20230113 $b ABA008
- 991 __
- $a 20230118155248 $b ABA008
- 999 __
- $a ok $b bmc $g 1885634 $s 1180863
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 166 $c 4 $d 386-392 $e 20210810 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK138 $a Pubmed-20230113